Jounce Therapeutics to Participate in Upcoming Virtual Investor Conferences in September
02 sept. 2020 16h01 HE
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
Novan Announces Receipt of Written Minutes from Type C Meeting with FDA Regarding Development of SB206
30 avr. 2020 16h05 HE
|
Novan, Inc.
Enrollment of first patient targeted for September 2020Top line results expected late in the second quarter of 2021 based on anticipated timeline MORRISVILLE, N.C., April 30, 2020 (GLOBE NEWSWIRE)...
Novan Announces Comprehensive Evaluation of Strategic and Financial Alternatives
20 avr. 2020 16h05 HE
|
Novan, Inc.
Engages H.C. Wainwright & Co. as strategic and financial advisorNITRICIL™ nitric oxide technology platform has enabled multiple early and late-stage pipeline opportunities in dermatology, women’s...
Canbiola to Discuss its CBD Business and Strategy at H.C. Wainwright 21st Annual Global Investment Conference
09 sept. 2019 07h30 HE
|
Canbiola, Inc.
HICKSVILLE, NY, Sept. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of hemp-derived...
VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference
05 sept. 2019 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
ObsEva SA to Participate in Upcoming Investor Conferences
30 août 2019 01h00 HE
|
ObsEva SA
Geneva, Switzerland and Boston, MA – August 30, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
28 août 2019 08h00 HE
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
RedHill Biopharma to Present at Upcoming Investor Conferences in September
27 août 2019 07h00 HE
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty...
Emerald Bioscience to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
08 avr. 2019 08h30 HE
|
Emerald Bioscience, Inc.
LONG BEACH, CA, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Emerald Bioscience, Inc. (OTCQB: EMBI), a biopharmaceutical company focused on developing bioengineered cannabinoid-based...
InspireMD to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York City
04 sept. 2018 07h30 HE
|
InspireMD, Inc.
TEL AVIV, ISRAEL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...